214 related articles for article (PubMed ID: 34021690)
41. Attaching and effacing pathogens: the effector ABC of immune subversion.
Riebisch AK; Mühlen S
Future Microbiol; 2020 Jul; 15():945-958. PubMed ID: 32716209
[TBL] [Abstract][Full Text] [Related]
42. Host Cell Targeting by Enteropathogenic Bacteria T3SS Effectors.
Pinaud L; Sansonetti PJ; Phalipon A
Trends Microbiol; 2018 Apr; 26(4):266-283. PubMed ID: 29477730
[TBL] [Abstract][Full Text] [Related]
43. Modelling of infection by enteropathogenic Escherichia coli strains in lineages 2 and 4 ex vivo and in vivo by using Citrobacter rodentium expressing TccP.
Girard F; Crepin VF; Frankel G
Infect Immun; 2009 Apr; 77(4):1304-14. PubMed ID: 19188355
[TBL] [Abstract][Full Text] [Related]
44. The cell death response to enteropathogenic Escherichia coli infection.
Wong Fok Lung T; Pearson JS; Schuelein R; Hartland EL
Cell Microbiol; 2014 Dec; 16(12):1736-45. PubMed ID: 25266336
[TBL] [Abstract][Full Text] [Related]
45. Here, there, and everywhere: How pathogenic Escherichia coli sense and respond to gastrointestinal biogeography.
Woodward SE; Krekhno Z; Finlay BB
Cell Microbiol; 2019 Nov; 21(11):e13107. PubMed ID: 31454133
[TBL] [Abstract][Full Text] [Related]
46. The Prophages of
Magaziner SJ; Zeng Z; Chen B; Salmond GPC
J Bacteriol; 2019 May; 201(9):. PubMed ID: 30782635
[TBL] [Abstract][Full Text] [Related]
47.
Krekhno Z; Woodward SE; Serapio-Palacios A; Peña-Díaz J; Moon KM; Foster LJ; Finlay BB
Gut Microbes; 2024; 16(1):2308049. PubMed ID: 38299318
[TBL] [Abstract][Full Text] [Related]
48. The enterohemorrhagic Escherichia coli effector protein NleF binds mammalian Tmp21.
Olsen RL; Echtenkamp F; Cheranova D; Deng W; Finlay BB; Hardwidge PR
Vet Microbiol; 2013 May; 164(1-2):164-70. PubMed ID: 23434013
[TBL] [Abstract][Full Text] [Related]
49. Novel Effector Protein EspY3 of Type III Secretion System from Enterohemorrhagic
Larzábal M; Marques Da Silva W; Riviere NA; Cataldi ÁA
Microorganisms; 2018 Oct; 6(4):. PubMed ID: 30373243
[TBL] [Abstract][Full Text] [Related]
50. The bacterial virulence factor NleA undergoes host-mediated O-linked glycosylation.
Burns L; Giannakopoulou N; Zhu L; Xu YZ; Khan RH; Bekal S; Schurr E; Schmeing TM; Gruenheid S
Mol Microbiol; 2023 Feb; 119(2):161-173. PubMed ID: 36196760
[TBL] [Abstract][Full Text] [Related]
51. Oral Administration with Live Attenuated Citrobacter rodentium Protects Immunocompromised Mice from Lethal Infection.
Wang S; Xia X; Liu Y; Wan F
Infect Immun; 2022 Jul; 90(7):e0019822. PubMed ID: 35861565
[TBL] [Abstract][Full Text] [Related]
52. CRISPR Screen Reveals that EHEC's T3SS and Shiga Toxin Rely on Shared Host Factors for Infection.
Pacheco AR; Lazarus JE; Sit B; Schmieder S; Lencer WI; Blondel CJ; Doench JG; Davis BM; Waldor MK
mBio; 2018 Jun; 9(3):. PubMed ID: 29921669
[TBL] [Abstract][Full Text] [Related]
53. Extra! Extracellular Effector Delivery into Host Cells via the Type 3 Secretion System.
Kendall MM
mBio; 2017 May; 8(3):. PubMed ID: 28465427
[TBL] [Abstract][Full Text] [Related]
54. Identification of a Family of
Plaza N; Urrutia IM; Garcia K; Waldor MK; Blondel CJ
mSphere; 2021 Aug; 6(4):e0059921. PubMed ID: 34346702
[TBL] [Abstract][Full Text] [Related]
55. The type III secretion effector NleF of enteropathogenic Escherichia coli activates NF-κB early during infection.
Pallett MA; Berger CN; Pearson JS; Hartland EL; Frankel G
Infect Immun; 2014 Nov; 82(11):4878-88. PubMed ID: 25183730
[TBL] [Abstract][Full Text] [Related]
56. Attaching and effacing bacterial effector NleC suppresses epithelial inflammatory responses by inhibiting NF-κB and p38 mitogen-activated protein kinase activation.
Sham HP; Shames SR; Croxen MA; Ma C; Chan JM; Khan MA; Wickham ME; Deng W; Finlay BB; Vallance BA
Infect Immun; 2011 Sep; 79(9):3552-62. PubMed ID: 21746856
[TBL] [Abstract][Full Text] [Related]
57. The Serine Protease EspC from Enteropathogenic Escherichia coli Regulates Pore Formation and Cytotoxicity Mediated by the Type III Secretion System.
Guignot J; Segura A; Tran Van Nhieu G
PLoS Pathog; 2015 Jul; 11(7):e1005013. PubMed ID: 26132339
[TBL] [Abstract][Full Text] [Related]
58. Attachment of Enterohemorrhagic Escherichia coli to Host Cells Reduces O Antigen Chain Length at the Infection Site That Promotes Infection.
Liu B; Qian C; Wu P; Li X; Liu Y; Mu H; Huang M; Zhang Y; Jia T; Wang Y; Wang L; Zhang X; Huang D; Yang B; Feng L; Wang L
mBio; 2021 Dec; 12(6):e0269221. PubMed ID: 34903041
[TBL] [Abstract][Full Text] [Related]
59. Advances and Challenges in Studying Type III Secretion Effectors of Attaching and Effacing Pathogens.
Slater SL; Frankel G
Front Cell Infect Microbiol; 2020; 10():337. PubMed ID: 32733819
[No Abstract] [Full Text] [Related]
60. Quantitative proteomic analysis of type III secretome of enteropathogenic Escherichia coli reveals an expanded effector repertoire for attaching/effacing bacterial pathogens.
Deng W; Yu HB; de Hoog CL; Stoynov N; Li Y; Foster LJ; Finlay BB
Mol Cell Proteomics; 2012 Sep; 11(9):692-709. PubMed ID: 22661456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
